Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2000
07/05/2000CN1259017A Non-spherical and non-platelet pyrithione salts
07/05/2000CN1258677A Synthesis and anticancer activity of conjugated phospholipid
07/05/2000CN1258675A Process and intermediate for producing 5-lipoxidase inhibitor
07/05/2000CN1258674A Pyrone carboxylic acid derivate or its salt and antibiotic with the same as effective component
07/05/2000CN1258673A New imidazole derivate and its producing process
07/05/2000CN1258672A Amino-compound
07/05/2000CN1258532A Medicated cosmetics capable of being used to treat primary and secondary varicose vein simultaneously and its preparation
07/05/2000CN1258527A Fast-acting piles-treating Chinese medicine preparation
07/05/2000CN1258506A Nonatungsten trititanium silicate used as antineoplastic medicine
07/05/2000CN1258505A Animal's parasiticide emulsion containing avermectin, ivermectin or chlorocyaniosaliamine
07/05/2000CN1258504A Liposomes and their application in preparing medicine for delaying senility and directional reconstruction of cytomembrane phospholipid defect
07/05/2000CN1258503A Vitamine preparation
07/05/2000CN1258502A Anaesthetic
07/05/2000CN1258492A Amphoteric lipids dispersion body
07/05/2000CN1258457A Application of cholesterol biosynthesis inhibitor for reducing cholesterol content of poultry eggs
07/05/2000CN1258450A Natural plant disinfectant and its preparation
07/05/2000CN1054133C 17-spiromethylene steroids
07/05/2000CN1054124C Aminoquinoline derivatives and its application of salt
07/05/2000CN1054123C Process for producing carbamic acid derivatives
07/05/2000CN1054065C Rodgersflower rhizome extractive and medicine for relieving inflammation and pain with it as active constituent
07/05/2000CN1054055C Compound prepn. made from herb medicine and western medicine for treating poultry dysentery with white mucous stool
07/05/2000CN1054053C Medicine for reducing blood sugar and its preparing method
07/05/2000CN1054041C Process for preparing stabilized ascorbic acid composition
07/05/2000CN1054040C Preparation of ion exchange resins loaded with quinolonecarboxylic acid derivatives
07/05/2000CA2293928A1 A novel substituted alkyltetraamine derivative
07/05/2000CA2257804A1 Treatment of hiv-associated dysmorphia/dysmetabolic syndrome
07/04/2000US6084152 Method for producing transgenic cucumber that produces high levels of superoxide dismutase
07/04/2000US6084130 For treatment of central nervous system disorders
07/04/2000US6084120 β-Alkoxyacrylates against malaria
07/04/2000US6084110 Infusion preparation composed of a vitamin c preparation blended with an electrolyte infusion solution containing a magnesium stabilizer, e.g., magnesium acetate, lactate, chloride, sulfate; storage stability; injections; nutrients
07/04/2000US6084103 Forming a carbamate from methyl 4-nitro-(l)-phenylalaninate hydrochloride; reducing the nitro and ester groups; ring closure free of phosgene; forming a diazonium salt without using tin chloride; fischer reaction; migraines; 5ht1-agonist
07/04/2000US6084095 Including 6-amino-4-(3-bromoanilino)pyrido(3,2-d)pyrimidine; 4-(3-bromoanilino)-6-methylaminopyrido (3,2-d)pyrimidine; and 4-(3-bromoanilino)-6-methylaminopyrido(3,2-d)pyrimidine; useful in treating proliferative diseases such as cancer
07/04/2000US6084093 Substituted 1,4,7,10,13-pentaazacyclopentadecane macrocyclic ligands; manganese complexes of the ligand are mimics of superoxide dismutase; useful as therapeutic agents for inflammatory diseases
07/04/2000US6084090 Human papilloma virus anti-sense oligonucleotides
07/04/2000US6084085 Inducing resistance to tumor growth with soluble IGF-1 receptor
07/04/2000US6084084 Nucleotide and amino acid sequences; for anticonvulsants, neuroprotectants, analgesics and cognition enhancers; for diagnosis and therapy of related nervous system disorders
07/04/2000US6084080 Breviscapinum and extracting process thereof from erigeron breviscapus
07/04/2000US6084075 Agonist and antagonist antibodies to the chemokine receptor-2 (CCR2)
07/04/2000US6084067 CTLA4/CD28 ligands and uses therefor
07/04/2000US6083996 Topical compositions for NSAI drug delivery
07/04/2000US6083995 Administering the patient 2,4-dichlorobenzyl alcohol and amylmetacresol to cure human immunodeficiency viral infections
07/04/2000US6083993 Method for treating bronchospasm using optically pure R(-) albuterol
07/04/2000US6083992 Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial infections
07/04/2000US6083991 Anti-arrhythmic composition and methods of treatment
07/04/2000US6083990 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
07/04/2000US6083989 Administering to the patient suffering from inflammatory bowl movement an n-substituted aryl nitron compound or salt
07/04/2000US6083988 Azulenyl nitrone spin trapping agents, methods of making and using same
07/04/2000US6083987 Phenylenediamine derivative, radical scavenger, brain-infarction depressant, and brain-edema depressant
07/04/2000US6083986 Amine derivative substituted indane compound useful for the treatment of cardiac arrhythmias and cell proliferative disorders
07/04/2000US6083984 Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in the treatment of various disorders
07/04/2000US6083982 Stimulating sodium excretion in the urine of a mammal comprising administering to the mammal a alkoxyalkyl or hydroxy alkyl substituted phenolic compound
07/04/2000US6083981 Sulfonamide substituted aspartic acid interleukin-1β converting enzyme inhibitors
07/04/2000US6083979 Administering geranylgeraniol and lovastatin to a mammal for blocking aberrant ras signaling while avoiding excessive cell toxicity
07/04/2000US6083978 Compounds with a sulfamate group
07/04/2000US6083976 Reacting aloesin with a substituted or unsubsituted alkyl group containing a halogen leaving group in the presence of a base
07/04/2000US6083975 Administering to the patients a substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)alkyl)-1,4-benzodioxin dicarbonyl compounds as antiobesity agent
07/04/2000US6083974 Benzothiophenecarboxamide derivatives and PGD2 antagonists comprising them
07/04/2000US6083973 Methods for inhibiting mucin secretion using RAR α selective antagonists
07/04/2000US6083971 Certain oxopyrolo-pyrrole derivatives having thrombin inhibiting activity
07/04/2000US6083968 A fungicide; 1,1-difluoro-1-ethyl thienyl or ethyl thienyl oxides-2-(2,4-substituted phenyl)-3-(1h-1,2,4-tria zol-1-yl)-2-oxy or hydroxy compound
07/04/2000US6083967 Antimicrobial agents; assay for determining the inhibitory activity of oxazolidinones to human monoamine oxidase
07/04/2000US6083966 Thiazoline acid derivatives
07/04/2000US6083965 Antiparasitic agents
07/04/2000US6083963 Treatment of various chronic and acute skin conditions, particularly acne and photoaging
07/04/2000US6083962 Agonist-anatagonist combination to reduce the use of nicotine and other drugs
07/04/2000US6083960 Constrained somatostatin agonists and antagonists
07/04/2000US6083959 Quinoline derivatives, processes for their preparation and their use as medicaments
07/04/2000US6083958 Anti-HIV composition containing imidazole derivative
07/04/2000US6083957 Heterocyclic compounds and their preparation and use
07/04/2000US6083956 Optically pure androgen mediator
07/04/2000US6083955 Having a high affinity for drugs, especially endoserine receptors
07/04/2000US6083954 Method of treating cystic fibrosis
07/04/2000US6083953 Treating herpes simplex virus or cytomegalovirus infections; valganciclovir hydrochloride in crystalline form; antiviral; oral administration
07/04/2000US6083952 Compounds
07/04/2000US6083951 Aryl-substituted pyrimidine sulphonamide compounds as endothelin antagonists
07/04/2000US6083950 Treatment of peripheral vascular disease, congestive heart failure, hypertension and especially benign prostatic hypertrophy
07/04/2000US6083948 Treating anxiety, depression, and other psychiatric and neurological disorders
07/04/2000US6083947 Administering an effective amount of a compound that enhances the stimulation of alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (?ampa?) receptors in said subject
07/04/2000US6083945 Cyclic ureas useful as antiarrhythmic and antifibrillatory agents
07/04/2000US6083944 Enzyme inhibitors; treatment of various debilitating disorders
07/04/2000US6083943 For treatment of gastrointestinal disorders, central nervous system disorders, allergy, inflammatory diseases, asthma, pain, emesis or migraine in mammals, especially humans
07/04/2000US6083941 Inhibition of NMDA receptor activity by pregnenolone sulfate derivatives
07/04/2000US6083940 Method and composition for effecting contraception in a mammalian male
07/04/2000US6083938 Pyridinylbisphosphonates for use as a therapeutical agent
07/04/2000US6083936 Treatment of estrogen-dependent disorders such as estrogen-dependent cancers; also useful in diagnostic techniques such as magnetic resonance imaging and magnetic resonance spectroscopy
07/04/2000US6083935 Consisting essentially of an effective amount of n-acetylglucosamine and electrolytes
07/04/2000US6083933 Instilling composition comprising carrier and chondroitin sulfate to alleviate symptoms of bladder or urinary tract condition
07/04/2000US6083932 Pharmaceutical compositions derived from ginseng and methods of treatment using same
07/04/2000US6083931 Method of inhibiting cancer metastasis
07/04/2000US6083930 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
07/04/2000US6083929 Immunogens and tumor markers; detection of cancer
07/04/2000US6083928 Applying topically to skin composition containing lipopolysaccharide extracted from klebsiella pneumoniae strain
07/04/2000US6083927 Improver containing galactosulfate oligosaccharide
07/04/2000US6083926 Water soluble vitamin B12 receptor modulating agents and methods related thereto
07/04/2000US6083924 DnaB of staphylococcus aureus
07/04/2000US6083922 Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
07/04/2000US6083920 Treating nervous system disorders by administering lysocerebroside or lysosphingomyelin
07/04/2000US6083904 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
07/04/2000US6083903 Boronic ester and acid compounds, synthesis and uses
07/04/2000US6083900 Use of an organopolysiloxane for the fixing and/or sustained release of perfume